On Thursday 19 October, the European Commission announced that it had imposed fines totalling €13.4 million on six companies in the pharmaceuticals sector that engaged in a cartel between 1 November 2005 and 17 September 2019: Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm, with C2 PHARMA benefitting from the European leniency programme as it disclosed the cartel to the Commission and was exempted from fines.
The cartel, which took place within...